CMRX logo

Chimerix (CMRX) Company Overview

Profile

Full Name:

Chimerix, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 11, 2013

Indexes:

Not included

Description:

Chimerix (CMRX) is a biopharmaceutical company focused on developing antiviral therapies. It aims to improve treatments for serious viral infections, particularly in immunocompromised patients. The company works on innovative drugs to enhance patient outcomes and address unmet medical needs in the healthcare market.

Key Details

Price

$8.44

Annual Revenue

$324.00 K(-99.04% YoY)

Annual EPS

-$0.93(-147.94% YoY)

Annual ROE

-36.50%

Beta

0.76

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy
Dec 30, 24 HC Wainwright & Co.
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Wedbush
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Mar 1, 24 HC Wainwright & Co.
Buy
Aug 17, 23 Wedbush
Outperform
Aug 16, 23 HC Wainwright & Co.
Buy
Aug 4, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Chimerix?
  • Does Chimerix pay dividends?
  • What sector is Chimerix in?
  • What industry is Chimerix in?
  • What country is Chimerix based in?
  • When did Chimerix go public?
  • Is Chimerix in the S&P 500?
  • Is Chimerix in the NASDAQ 100?
  • Is Chimerix in the Dow Jones?
  • When was Chimerix's last earnings report?
  • When does Chimerix report earnings?
  • Should I buy Chimerix stock now?

What is the ticker symbol for Chimerix?

The ticker symbol for Chimerix is NASDAQ:CMRX

Does Chimerix pay dividends?

No, Chimerix does not pay dividends

What sector is Chimerix in?

Chimerix is in the Healthcare sector

What industry is Chimerix in?

Chimerix is in the Biotechnology industry

What country is Chimerix based in?

Chimerix is headquartered in United States

When did Chimerix go public?

Chimerix's initial public offering (IPO) was on April 11, 2013

Is Chimerix in the S&P 500?

No, Chimerix is not included in the S&P 500 index

Is Chimerix in the NASDAQ 100?

No, Chimerix is not included in the NASDAQ 100 index

Is Chimerix in the Dow Jones?

No, Chimerix is not included in the Dow Jones index

When was Chimerix's last earnings report?

Chimerix's most recent earnings report was on Feb 28, 2025

When does Chimerix report earnings?

The date for Chimerix's next earnings report has not been announced yet

Should I buy Chimerix stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions